Chemfab Alkalis Limited , a prominent player in the chemical industry, has taken a significant step towards diversification by incorporating a wholly owned subsidiary, Chemfab Hiitech Piping Limited (CHPL). This strategic move marks the company's entry into the manufacturing and trading of OPVC (Oriented Polyvinyl Chloride) pipes and fittings.

Key Details of the New Subsidiary

Business Focus

The newly formed subsidiary, CHPL, will focus on:

• Manufacturing high-quality OPVC pipes of various sizes and varieties
• Producing fittings for OPVC pipes
• Buying, selling, importing, and exporting OPVC products

These products are expected to cater to a wide range of industries, including:

• Agricultural sector
• Engineering industry
• Electrical industry
• Mechanical industry

Strategic Implications

This move by Chemfab Alkalis Limited signifies a calculated expansion into a new market segment. The OPVC pipe industry is known for its growing demand in various sectors, particularly in infrastructure and agriculture. By establishing CHPL, Chemfab Alkalis is positioning itself to capitalize on these opportunities and potentially diversify its revenue streams.

Regulatory Compliance

The company has duly informed the stock exchanges about this development, adhering to the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. This transparency ensures that shareholders and potential investors are kept informed about significant corporate actions that may impact the company's future performance.

While the immediate financial impact of this new subsidiary may be limited, given the initial investment of Rs. 5.00 lakh, the long-term strategic benefits could be substantial. As CHPL begins its operations and establishes its presence in the OPVC market, it will be interesting to observe how this diversification affects Chemfab Alkalis Limited's overall business performance and market position.

Chemfab Alkalis Limited has disclosed an amended trading plan for its Chief Executive Officer, V.M. Srinivasan, providing additional clarity on the price action for his proposed share sale.

Key Details of the Amended Trading Plan

The amended plan, submitted on November 10, 2025, includes the following key points:

Background and Amendments

The original trading plan was approved on November 12, 2024, and submitted to the stock exchanges on November 13, 2024. The amendment was necessary to include price action details that were initially omitted.

Current Shareholding and Trading Conditions

Mr. Srinivasan currently holds 259,606 equity shares in Chemfab Alkalis Limited. The amended plan maintains all other terms and conditions from the original submission, including:

1. A mandatory cool-off period of 120 days.
2. No trading during specified no-trading periods.
3. A commitment not to trade for market abuse.
4. Confirmation that the insider is not in possession of any unpublished price-sensitive information.

Pricing Strategy

The price range for the proposed sale has been set between the closing price on the day before the plan's submission and up to 20% lower than that closing price. This strategy aims to provide flexibility while ensuring compliance with insider trading regulations.

Compliance and Irrevocability

The trading plan, once approved, is irrevocable under any circumstances. Mr. Srinivasan is obligated to implement the trades as outlined in the plan without deviation. This commitment aligns with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.

Chemfab Alkalis Limited's Compliance Officer, Bharatraj Panchal, has approved the amended trading plan on November 10, 2025. This disclosure demonstrates the company's commitment to transparency and compliance with regulatory requirements in matters of insider trading and corporate governance.